SCHEMBL3579871

SCHEMBL3579871

COC(=O)Cn1nc(CC(=O)OCc2ccccc2)cc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
MAPK1 P28482 1/20 0.49
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 2/20 0.46
GAA P10253 1/20 0.46
LMNA P02545 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
CYP2C9 P11712 1/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
PTGER1 P34995 5/20 0.42
MAPT P10636 3/20 0.42
TDP1 Q9NUW8 1/20 0.42
TSHR P16473 3/20 0.42
NPC1 O15118 2/20 0.42
TP53 P04637 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3579870 0.95 ALDH1A1 (0.46) ALDH1A1L3MBTL1MAPK1CYP1A2CYP2C19
SCHEMBL13807633 0.86 TDP1 (0.49) ALDH1A1L3MBTL1MAPK1CYP1A2CYP2C19
SCHEMBL15156607 0.81 LMNA (0.56) ALDH1A1L3MBTL1MAPK1CYP1A2CYP2C19
SCHEMBL13807581 0.80 ALDH1A1 (0.44) ALDH1A1L3MBTL1MAPK1CYP1A2CYP2C19
SCHEMBL3579752 0.79 LMNA (0.60) ALDH1A1L3MBTL1CYP1A2GAALMNA
SCHEMBL26924634 0.73 L3MBTL1 (0.49) ALDH1A1L3MBTL1CYP1A2CYP2C19GAA
SCHEMBL16416437 0.72 CYP1A2 (0.47) ALDH1A1L3MBTL1MAPK1CYP1A2CYP2C19
SCHEMBL15156935 0.72 CYP1A2 (0.44) ALDH1A1L3MBTL1MAPK1CYP1A2CYP2C19
SCHEMBL20037188 0.71 LMNA (0.66) ALDH1A1CYP1A2GAALMNASMN1; SMN2
SCHEMBL14446963 0.71 ALDH1A1 (0.52) ALDH1A1L3MBTL1MAPK1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286191-A1 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators MERCK SHARP & DOHME CORP. 2010-11-11 US disclosed
US-20090030012-A1 Pyridine, Pyrimidine and Pyrazine Derivatives as Cxcr3 Receptor Modulators MERCK SHARP & DOHME CORP. 2009-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030012-A1 Pyridine, Pyrimidine and Pyrazine Derivatives as Cxcr3 Receptor Modulators CXCR3, CXCR1, CXCR5 ALDH1A1 1431/4885L3MBTL1 4648/4885MAPK1 839/4885
US-20100286191-A1 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators CXCR3, CXCR1, CXCR2 ALDH1A1 971/4885L3MBTL1 4141/4885MAPK1 1173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.